TRexBio

TRex Bio

South San Francisco, United States · Founded 2018 · $219.0M raised

Employees
11–50
Founded
2018
Business Model
B2B
Website
trex.bio
Total Funding
$219.0M
Last Round
$50.0M Extension RoundJan 2026
Rounds
4

About

TRexBio is a South San Francisco-based clinical-stage biotechnology company developing purpose-built biologics that restore immune balance in autoimmune and inflammatory diseases. Founded in 2018 with seed funding from SV Health Investors, TRexBio's platform leverages deep tissue biology to design biologics capable of selectively modulating immune responses. The company raised M in a Series B extension in January 2026 to advance its pipeline including programs for atopic dermatitis.

Summary

TRexBio is a Biotech company based in South San Francisco, United States, founded in 2018. It has raised $219.0M in total across 4 rounds, most recently a $50.0M Extension Round round in Jan 2026. Investors include Delos Capital, Polaris Partners and SV Health Investors.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundJan 2026
$50.0M

Sign up to see all 4 rounds

Series A through Extension Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

TRexBio on Indexed.vc
<a href="https://indexed.vc/companies/trexbio"><img src="https://indexed.vc/api/badge/company/trexbio" alt="TRexBio on Indexed.vc" width="260" height="76" /></a>